Health Care

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. Ensysce Biosciences...

  Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. NeuroSense Therapeutics Ltd. (...

Lexicon Pharmaceuticals (NASDAQ: LXRX) reported positive topline results from the Phase 2 proof-of-concept study of its lead candidate LX9211 in painful diabetic neuropathy. The RELIEF-DPN-1 is the first of two Phase 2 proof-of-concept study designed to evaluate LX9211 in patients with neuropathic...

The opioid crisis has raised public awareness about the dire state of pain-management options for the estimated 50 million Americans with chronic pain.  As the crisis renews the call for researchers to find a pain relief method that is both powerful and safe, some pharmaceutical companies like...

The Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), started shipping monkeypox tests to five commercial laboratory companies to increase monkeypox testing capacity and access. The companies include Aegis Science, Laboratory...

Keybanc cut Coupa Software Incorporated (NASDAQ: COUP) price target from $125 to $100. Coupa Software shares rose 0.9% to $72.74 in pre-market trading. SVB Leerink reduced Vincerx Pharma, Inc. (NASDAQ: VINC) price target from $19 to $6. Vincerx Pharma shares rose 1.1% to close at $1.83 on...

Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday. Piper Sandler reduced JOANN Inc. (NASDAQ: JOAN) price target from $11 to $6. JOANN shares fell 0.8% to $6.31 in pre-market trading. HC Wainwright & Co. lowered the price...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.89% to 32,953.50 while the NASDAQ fell 2.44% to 12,016.38. The S&P also fell, dropping, 1.52% to 4,113.52. Also check this: Home Depot And 2 Other Stocks...

U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.99% to 32,919.61 while the NASDAQ fell 2.61% to 11,995.68. The S&P also fell, dropping, 1.66% to 4,107.48. Also check this: Home Depot And 2 Other Stocks...

  Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. Energy Focus, Inc. (NASDAQ: EFOI) shares jumped 32.8% to $1.4740 after declining around 9% on Thursday....

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.47% to 33,093.44 while the NASDAQ fell 1.49% to 12,132.82. The S&P also fell, dropping, 1% to 4,135.19. Also check this: Home Depot And 2...

Gold futures traded lower this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go...

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia. VivoPower International PLC (NASDAQ:...